InsiderTrades.com logo

CLRB Insider Trading

Insider Ownership Percentage: 5.04%
Insider Buying (Last 12 Months): $133,150.00
Insider Selling (Last 12 Months): $0.00

Cellectar Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Cellectar Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cellectar Biosciences Share Price & Price History

Current Price: $3.80
Price Change: ▲ Price Increase of +0.11 (2.98%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for CLRB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cellectar Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/2/2025Chad J KoleanCFOBuy5,000$4.99$24,950.006,418View SEC Filing Icon  
7/2/2025James V CarusoCEOBuy10,000$4.99$49,900.0011,638View SEC Filing Icon  
7/2/2025Jarrod LongcorCOOBuy10,000$4.99$49,900.0012,768View SEC Filing Icon  
1/10/2025Jarrod LongcorCOOBuy1,000$8.40$8,400.002,771View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Cellectar Biosciences (NASDAQ:CLRB)

16.41% of Cellectar Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CLRB by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cellectar Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Citadel Advisors LLC18,526$0.10M0.0%N/A0.580%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP13,033$73K0.0%N/A0.408%Search for SEC Filing on Google Icon
10/29/2025Sequoia Financial Advisors LLC10,783$60K0.0%N/A0.338%Search for SEC Filing on Google Icon
8/13/2025Riverview Capital Advisers LLC10,500$75K0.0%N/A0.580%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC14,439$0.10M0.0%-96.7%0.798%Search for SEC Filing on Google Icon
5/12/2025Simplex Trading LLC173,129$54K0.0%+331.3%0.376%Search for SEC Filing on Google Icon
5/8/2025Baader Bank Aktiengesellschaft172,940$55K0.0%N/A0.375%Search for SEC Filing on Google Icon
5/8/2025XTX Topco Ltd104,323$33K0.0%+122.6%0.226%Search for SEC Filing on Google Icon
4/23/2025Sequoia Financial Advisors LLC203,260$64K0.0%+1,301.8%0.441%Search for SEC Filing on Google Icon
2/17/2025Squarepoint Ops LLC520,240$0.16M0.0%N/A1.129%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE206,783$62K0.0%+25.3%0.449%Search for SEC Filing on Google Icon
2/13/2025ADAR1 Capital Management LLC585,261$0.18M0.0%-42.7%1.270%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.182,403$55K0.0%+687.3%0.396%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC120,497$0.26M0.0%-30.0%0.292%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC352,452$0.75M0.0%+3.3%0.869%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC120,497$0.26M0.0%-30.0%0.297%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd53,022$0.11M0.0%-16.2%0.131%Search for SEC Filing on Google Icon
11/6/2024Oppenheimer & Co. Inc.12,500$27K0.0%N/A0.031%Search for SEC Filing on Google Icon
10/30/2024Rosalind Advisors Inc.3,671,550$7.86M4.9%+35.7%10.241%Search for SEC Filing on Google Icon
10/22/2024Sequoia Financial Advisors LLC23,800$51K0.0%N/A0.066%Search for SEC Filing on Google Icon
8/20/2024Nantahala Capital Management LLC1,833,325$4.58M0.3%-2.1%5.114%Search for SEC Filing on Google Icon
8/16/2024Coastal Bridge Advisors LLC11,000$28K0.0%-31.3%0.031%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd63,304$0.16M0.0%+432.4%0.177%Search for SEC Filing on Google Icon
8/7/2024AIGH Capital Management LLC3,036,187$7.59M2.4%+8.2%8.469%Search for SEC Filing on Google Icon
7/12/2024Rosalind Advisors Inc.2,705,616$6.76M5.0%+335.4%7.547%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.1,191,081$4.74M0.0%+146.7%3.322%Search for SEC Filing on Google Icon
4/25/2024Rosalind Advisors Inc.621,478$2.47M2.3%-69.0%1.926%Search for SEC Filing on Google Icon
2/14/2024ADAR1 Capital Management LLC1,378,082$3.82M1.4%N/A11.213%Search for SEC Filing on Google Icon
2/12/2024AIGH Capital Management LLC1,915,220$5.31M2.1%+182.7%15.584%Search for SEC Filing on Google Icon
2/9/2024Worth Venture Partners LLC693,909$1.92M1.0%+148.6%5.646%Search for SEC Filing on Google Icon
1/1/2024Vanguard Group Inc.175,884$0.46M0.0%+2.3%1.431%Search for SEC Filing on Google Icon
11/15/2023Worth Venture Partners LLC279,123$0.74M0.4%-11.0%2.808%Search for SEC Filing on Google Icon
11/15/2023Acuta Capital Partners LLC121,300$0.32M0.2%N/A1.220%Search for SEC Filing on Google Icon
11/13/2023AIGH Capital Management LLC677,511$1.79M0.8%-16.7%6.816%Search for SEC Filing on Google Icon
7/21/20231900 Wealth Management LLC18,000$35K0.0%+50.0%0.185%Search for SEC Filing on Google Icon
2/16/2023AIGH Capital Management LLC931,888$1.59M0.5%+434.3%9.924%Search for SEC Filing on Google Icon
11/16/2022Maven Securities LTD25,000$84K0.0%-93.8%0.266%Search for SEC Filing on Google Icon
11/14/2022Worth Venture Partners LLC41,636$0.14M0.1%-90.9%0.444%Search for SEC Filing on Google Icon
11/14/2022Maven Securities LTD25,000$84K0.0%-93.8%0.266%Search for SEC Filing on Google Icon
11/3/2022ACT Capital Management LLC21,750$73K0.1%-90.0%0.356%Search for SEC Filing on Google Icon
10/31/20221900 Wealth Management LLC12,000$40K0.0%N/A0.196%Search for SEC Filing on Google Icon
5/12/2022AIGH Capital Management LLC1,837,046$1.26M0.3%+104.9%3.007%Search for SEC Filing on Google Icon
4/27/20221900 Wealth Management LLC120,000$83K0.0%+100.0%0.196%Search for SEC Filing on Google Icon
2/14/2022Maven Securities LTD400,000$0.27M0.0%-60.4%0.655%Search for SEC Filing on Google Icon
2/10/2022AIGH Capital Management LLC896,590$0.60M0.2%N/A1.467%Search for SEC Filing on Google Icon
11/15/2021Franklin Resources Inc.142,400$0.13M0.0%N/A0.233%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC447,074$0.41M0.0%-55.8%0.732%Search for SEC Filing on Google Icon
11/5/2021Cozad Asset Management Inc.51,000$47K0.0%+64.5%0.083%Search for SEC Filing on Google Icon
8/16/2021State Street Corp147,846$0.18M0.0%N/A0.242%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cellectar Biosciences logo
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.
Read More on Cellectar Biosciences

Today's Range

Now: $3.80
Low: $3.61
High: $3.83

50 Day Range

MA: $3.99
Low: $2.82
High: $6.17

52 Week Range

Now: $3.80
Low: $2.71
High: $44.70

Volume

14,102 shs

Average Volume

68,389 shs

Market Capitalization

$16.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.47

Who are the company insiders with the largest holdings of Cellectar Biosciences?

Cellectar Biosciences' top insider investors include:
  1. Jarrod Longcor (COO)
  2. James V Caruso (CEO)
  3. Chad J Kolean (CFO)
Learn More about top insider investors at Cellectar Biosciences.

Who are the major institutional investors of Cellectar Biosciences?

Cellectar Biosciences' top institutional investors include:
  1. Citadel Advisors LLC — 0.58%
  2. Dimensional Fund Advisors LP — 0.41%
  3. Sequoia Financial Advisors LLC — 0.34%
Learn More about top institutional investors of Cellectar Biosciences stock.

Which major investors are buying Cellectar Biosciences stock?

During the previous quarter, CLRB stock was acquired by institutional investors including:
  1. Citadel Advisors LLC
  2. Dimensional Fund Advisors LP
  3. Sequoia Financial Advisors LLC
In the previous year, these company insiders have bought Cellectar Biosciences stock:
  1. Jarrod Longcor (COO)
  2. James V Caruso (CEO)
  3. Chad J Kolean (CFO)
Learn More investors buying Cellectar Biosciences stock.